GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.440
-0.230 (-13.77%)
At close: Apr 3, 2025, 4:00 PM
1.380
-0.060 (-4.17%)
Pre-market: Apr 4, 2025, 7:28 AM EDT

GRI Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-8.21-13.04-3.22-1.56-2.53
Depreciation & Amortization
000.050.050.06
Other Amortization
-2.10.220.150.71
Stock-Based Compensation
0.150.390.03-0.28
Other Operating Activities
-0.11-0.130.33-0.05-
Change in Accounts Payable
-0.392.160.90.05-0.03
Change in Other Net Operating Assets
-0.06-0.480.620.510.68
Operating Cash Flow
-8.61-8.99-1.09-0.85-0.83
Capital Expenditures
--0.01-0--
Investing Cash Flow
--0.01-0--
Short-Term Debt Issued
-1.441.540.50.25
Total Debt Issued
-1.441.540.50.25
Short-Term Debt Repaid
--0.2-0.28--
Total Debt Repaid
--0.2-0.28--
Net Debt Issued (Repaid)
-1.251.260.50.25
Issuance of Common Stock
13.8712.26-0.10.5
Repurchase of Common Stock
-0--0.12--
Other Financing Activities
-2.03-2.71-0.12--
Financing Cash Flow
11.8310.81.010.60.75
Net Cash Flow
3.221.8-0.08-0.25-0.08
Free Cash Flow
-8.61-9-1.09-0.85-0.83
Free Cash Flow Per Share
-46.98---54.86-55.04
Cash Interest Paid
--0.03-0
Levered Free Cash Flow
-5.55-5.25-1.81-1.61-
Unlevered Free Cash Flow
-5.55-6.05-1.62-1.42-
Change in Net Working Capital
0.56-0.530.290.8-
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q